GfK Updates US Diabetes Study

GfK Healthcare has added tailored reporting options to its Roper Global Diabetes Program, offering healthcare and related companies in the diabetes category access to patient data and market trends.

Since 1989, the US Diabetes Patient Market Study has included a series of multi-client tracking studies with diabetes patients in the US, Canada and Western Europe, as well as in Eastern Europe and Asia Pacific.

Through the enhanced version, clients can receive both standard and tailored reporting, as well as additional waves of data collection.

Standard deliverables include a market overview, and standard issue-centric reports that offer more detailed information on key topics.

Customized deliverables include customized reports, high-impact customized presentations and access to GfK Healthcare's Roper Diabetes Practice Leader for consulting engagements.

In addition, clients can now conduct customized research at syndicated prices by incorporating two extra waves of data collection to the traditional study. This allows sponsors to ask proprietary questions about switching behaviour, or track particular issues affecting their business.

Said David Jacobson, Roper Diabetes Practice Leader: 'We're confident the changes we're making to the Roper program will give marketers a better understanding of these and many other trends as well as more opportunities over time to track the issues impacting their brands.'

Earlier this week, GfK Healthcare launched a new unit, the Managed Markets Practice Area, offering research and consulting which supports every stage of the product life cycle and throughout the business planning process.

Web site: www.gfkhc.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.